Apeptico Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

Apeptico General Information

Description

Operator of a biotechnology company intended to target and treat chronic and life-threatening diseases. The company's peptide-based products concentrate on synthetically produced protein structures to avoid general risks associated with gene and cell technologies, enabling doctors to reduce treatment costs and shorten the therapy and treatment process.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Mariahilfer Straße 136
  • Top 1.15
  • Vienna, 1150
  • Austria
+43 0664
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Mariahilfer Straße 136
  • Top 1.15
  • Vienna, 1150
  • Austria
+43 0664

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apeptico Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private Completed Clinical Trials - Phase 2
6. Grant 01-Apr-2020 Completed Clinical Trials - Phase 2
5. Grant 08-Jul-2013 Completed Clinical Trials - Phase 2
4. Early Stage VC 16-May-2012 Completed Startup
3. Early Stage VC (Series A) 05-Aug-2010 Completed Startup
2. Seed Round 29-May-2009 $1.37M $1.37M Completed Startup
1. Accelerator/Incubator 01-Jan-2008 $2.91K $2.91K Completed Startup
To view Apeptico’s complete valuation and funding history, request access »

Apeptico Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to target and treat chronic and life-threatening diseases. The company's pe
Drug Discovery
Vienna, Austria
3 As of 2025

South San Francisco, CA
 

Aventura, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Apeptico Competitors (75)

One of Apeptico’s 75 competitors is Spruce Biosciences, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spruce Biosciences Formerly VC-backed South San Francisco, CA
NewAmsterdam Pharma Formerly VC-backed Aventura, FL
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
MBX Biosciences Formerly VC-backed Carmel, IN
PepGen Formerly VC-backed Boston, MA
You’re viewing 5 of 75 competitors. Get the full list »

Apeptico Patents

Apeptico Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4051307-A1 Peptide for prevention or treatment of covid-19 Active 08-May-2020
EP-4051307-B1 Peptide for prevention or treatment of covid-19 Active 08-May-2020
US-20250241978-A1 Peptide for prevention or treatment of covid-19 Pending 08-May-2020
WO-2021223894-A1 Peptide for prevention or treatment of covid-19 Inactive 08-May-2020
ES-2938574-T3 Peptide for the prevention or treatment of covid-19 Active 08-May-2020 A61K38/10
To view Apeptico’s complete patent history, request access »

Apeptico Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Apeptico FAQs

  • When was Apeptico founded?

    Apeptico was founded in 2008.

  • Where is Apeptico headquartered?

    Apeptico is headquartered in Vienna, Austria.

  • What is the size of Apeptico?

    Apeptico has 3 total employees.

  • What industry is Apeptico in?

    Apeptico’s primary industry is Drug Discovery.

  • Is Apeptico a private or public company?

    Apeptico is a Private company.

  • What is Apeptico’s current revenue?

    The current revenue for Apeptico is .

  • How much funding has Apeptico raised over time?

    Apeptico has raised $9.7M.

  • Who are Apeptico’s competitors?

    Spruce Biosciences, NewAmsterdam Pharma, Inovio Pharmaceuticals, MBX Biosciences, and PepGen are some of the 75 competitors of Apeptico.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process